A detailed history of Keebeck Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 4,157 shares of NVO stock, worth $368,767. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,157
Previous 4,136 0.51%
Holding current value
$368,767
Previous $590,000 16.27%
% of portfolio
0.07%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $2,500 - $3,053
21 Added 0.51%
4,157 $494,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $363,058 - $436,141
4,136 New
4,136 $427,000
Q1 2022

May 16, 2022

SELL
$93.1 - $112.54 $250,438 - $302,732
-2,690 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $257,917 - $314,945
2,690 New
2,690 $301,000
Q3 2020

Nov 02, 2020

SELL
$63.69 - $70.22 $43,946 - $48,451
-690 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$58.54 - $67.94 $40,392 - $46,878
690 New
690 $45,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Keebeck Wealth Management, LLC Portfolio

Follow Keebeck Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.